Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-17 5:35 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | BCLS II Investco LP | 10,719,110 13.000% | 5,342,754 (+99.38%) | View |
| 2024-12-17 4:00 pm Sale | 13D | NewAmsterdam Pharma Co N.V. NAMS | Forbion Capital Fund IV Cooperatief U.A. | 11,123,614 10.400% | -696,949 (-5.90%) | View |
| 2024-12-17 10:28 am Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | Frazier Life Sciences X L.P. | 16,416,751 15.300% | 3,784,713 (+29.96%) | View |
| 2024-11-15 4:29 pm Sale | 13D | NewAmsterdam Pharma Co N.V. NAMS | Forbion Capital Fund IV Cooperatief U.A. | 11,820,563 12.800% | -10,898 (-0.09%) | View |
| 2024-11-14 5:46 pm Purchase | 13G | NewAmsterdam Pharma Co N.V. NAMS | RA CAPITAL MANAGEMENT L.P. | 9,095,589 9.990% | 898,256 (+10.96%) | View |
| 2024-08-23 4:20 pm Sale | 13G | NewAmsterdam Pharma Co N.V. NAMS | AMGEN INC AMGN | 0 0.000% | -4,910,000 (Position Closed) | View |
| 2024-03-01 4:30 pm Unchanged | 13D | NewAmsterdam Pharma Co N.V. NAMS | BCLS II Investco LP | 5,376,356 6.000% | 0 (Unchanged) | View |
| 2024-02-21 11:11 am Unchanged | 13D | NewAmsterdam Pharma Co N.V. NAMS | Frazier Life Sciences X L.P. | 12,632,038 14.200% | 0 (Unchanged) | View |
| 2024-02-14 5:01 pm Sale | 13G | NewAmsterdam Pharma Co N.V. NAMS | RA CAPITAL MANAGEMENT L.P. | 8,197,333 9.900% | -1,136,000 (-12.17%) | View |
| 2024-02-14 10:12 am Purchase | 13G | NewAmsterdam Pharma Co N.V. NAMS | VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% | 1,500,000 (+22.99%) | View |
| 2023-09-19 9:30 pm Purchase | 13G | NewAmsterdam Pharma Co N.V. NAMS | Morningside Venture Investments Ltd | 4,060,923 4.930% | 4,060,923 (New Position) | View |
| 2023-08-15 4:02 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | Frazier Life Sciences X L.P. | 12,632,038 15.300% | 1,485,807 (+13.33%) | View |
| 2023-08-01 4:30 pm Purchase | 13G | NewAmsterdam Pharma Co N.V. NAMS | RA CAPITAL MANAGEMENT L.P. | 9,333,333 11.300% | 5,000,000 (+115.38%) | View |
| 2023-07-07 5:06 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | Forbion Capital Fund IV Cooperatief U.A. | 11,831,461 14.500% | 3,589,061 (+43.54%) | View |
| 2023-07-07 5:00 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | Forbion Capital Fund IV Cooperatief U.A. | 8,242,400 10.100% | 8,242,400 (New Position) | View |
| 2023-06-20 4:30 pm Purchase | 13G | NewAmsterdam Pharma Co N.V. NAMS | VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% | 6,524,565 (New Position) | View |
| 2023-06-13 5:04 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | BCLS II Investco LP | 5,376,356 6.600% | 1,376,356 (+34.41%) | View |
| 2023-06-09 3:47 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | Frazier Life Sciences X L.P. | 11,146,231 13.500% | 11,146,231 (New Position) | View |
| 2022-12-02 4:30 pm Purchase | 13G | NewAmsterdam Pharma Co N.V. NAMS | RA CAPITAL MANAGEMENT L.P. | 4,333,333 5.290% | 4,333,333 (New Position) | View |
| 2022-12-02 4:24 pm Purchase | 13D | NewAmsterdam Pharma Co N.V. NAMS | BCLS II Investco LP | 4,000,000 4.900% | 4,000,000 (New Position) | View |